Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-10 (IL-10)-producing regulatory T cells are a specialized subset of CD4+ T cells with potent immunosuppressive properties. These cells play a critical role in maintaining immune tolerance and preventing excessive inflammatory responses by secreting IL-10, an anti-inflammatory cytokine. Induction of these cells can occur in vitro and in vivo under specific conditions involving cytokines, antigen-presenting cell interactions, and pharmacological agents. Key subtypes include Tr1 cells (IL-10+ Foxp3-) and some Foxp3+ Tregs that also produce IL-10. Induction is influenced by factors like vitamin D3, dexamethasone, TGFβ, ERK1/ERK2 activation, STAT pathways, and transcription factors like c-Maf. These cells suppress immune responses through IL-10 secretion and sometimes cell-cell contact. They are crucial for controlling autoimmunity, allergy, chronic inflammation, transplant tolerance, and limiting tissue damage during infection.
Secretion of IL-10 to suppress effector immune responses; cell-cell contact-dependent suppression via PD-1 or CTLA-4
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-10-Producing Regulatory T Cells (IL-10-producing Tregs).